Back to Screener

Omnicell Inc (OMCL)

Price$38.28

Favorite Metrics

Price vs S&P 500 (26W)20.06%
Price vs S&P 500 (4W)6.19%
Market Capitalization$1.74B
P/E Ratio (Annual)848.38x

All Metrics

P/CF (Annual)13.68x
Book Value / Share (Quarterly)$27.36
P/TBV (Annual)2.02x
Indicated Dividend (Annual)$0.00
Revenue Growth (3Y)-2.94%
Cash Flow / Share (Quarterly)$1.49
Price vs S&P 500 (YTD)-19.64%
Gross Margin (TTM)42.49%
Net Profit Margin (TTM)0.17%
EPS (TTM)$0.04
10-Day Avg Trading Volume0.34M
EPS Excl Extra (TTM)$0.04
Revenue Growth (5Y)5.84%
EPS (Annual)$0.04
ROI (Annual)0.15%
Gross Margin (Annual)42.88%
Net Profit Margin (5Y Avg)1.36%
Cash / Share (Quarterly)$4.69
P/E Basic Excl Extra (TTM)848.38x
Revenue Growth QoQ (YoY)2.32%
EPS Growth (5Y)-43.01%
P/E Normalized (Annual)848.38x
ROA (Last FY)0.10%
Revenue Growth TTM (YoY)6.53%
EBITD / Share (TTM)$1.82
ROE (5Y Avg)1.35%
Operating Margin (TTM)0.44%
Cash Flow / Share (Annual)$1.49
P/B Ratio1.41x
P/B Ratio (Quarterly)1.65x
Net Income / Employee (Annual)$0
EV / Revenue (TTM)1.44x
Net Interest Coverage (TTM)-24.00x
ROA (TTM)0.10%
EV / EBITDA (TTM)20.39x
EPS Incl Extra (Annual)$0.04
Current Ratio (Annual)1.43x
Quick Ratio (Quarterly)1.14x
3-Month Avg Trading Volume0.62M
52-Week Price Return23.68%
EV / Free Cash Flow (Annual)25.58x
P/E Incl Extra (TTM)848.38x
Revenue / Employee (TTM)$0
Tangible BV / Share (Quarterly)$22.38
P/S Ratio (Annual)1.47x
Asset Turnover (Annual)0.60x
52-Week High$55.00
Operating Margin (5Y Avg)1.03%
EPS Excl Extra (Annual)$0.04
CapEx CAGR (5Y)1.92%
Tangible BV CAGR (5Y)7.39%
26-Week Price Return28.80%
Quick Ratio (Annual)1.14x
13-Week Price Return-24.53%
Total Debt / Equity (Annual)0.14x
Current Ratio (Quarterly)1.43x
Enterprise Value$1,711.947
Revenue / Share Growth (5Y)4.59%
Asset Turnover (TTM)0.58x
Book Value / Share Growth (5Y)3.89%
Revenue / Employee (Annual)$0
Inventory Turnover (Annual)7.14x
Pretax Margin (Annual)0.96%
Cash / Share (Annual)$4.69
3-Month Return Std Dev53.15%
Gross Margin (5Y Avg)44.86%
Net Income / Employee (TTM)$0
EBITDA CAGR (5Y)-2.77%
EBITDA Interim CAGR (5Y)-11.57%
ROE (Last FY)0.17%
Net Interest Coverage (Annual)6.18x
EPS Basic Excl Extra (Annual)$0.04
P/FCF (TTM)26.01x
Receivables Turnover (TTM)5.01x
EV / Free Cash Flow (TTM)25.58x
Total Debt / Equity (Quarterly)0.14x
EPS Incl Extra (TTM)$0.04
Receivables Turnover (Annual)5.01x
ROI (TTM)0.14%
P/S Ratio (TTM)1.47x
Pretax Margin (5Y Avg)1.43%
Revenue / Share (Annual)$25.56
Tangible BV / Share (Annual)$22.38
Forward P/E21.86x
Free OCF CAGR (5Y)-12.57%
Price vs S&P 500 (52W)-11.41%
P/E Ratio (TTM)848.38x
EPS Growth TTM (YoY)-83.38%
Year-to-Date Return-15.50%
5-Day Price Return9.34%
EPS Normalized (Annual)$0.04
ROA (5Y Avg)0.73%
Net Profit Margin (Annual)0.17%
Month-to-Date Return14.68%
Cash Flow / Share (TTM)$1.18
EBITD / Share (Annual)$1.81
EPS Growth (3Y)-28.66%
Operating Margin (Annual)0.44%
LT Debt / Equity (Annual)0.14x
P/CF (TTM)13.68x
ROI (5Y Avg)0.97%
P/E Excl Extra (TTM)848.38x
LT Debt / Equity (Quarterly)0.14x
EPS Basic Excl Extra (TTM)$0.04
P/TBV (Quarterly)2.02x
P/B Ratio (Annual)1.65x
Inventory Turnover (TTM)7.19x
Pretax Margin (TTM)0.96%
Book Value / Share (Annual)$27.36
Price vs S&P 500 (13W)-27.39%
Net Margin Growth (5Y)-45.73%
Beta0.89x
P/FCF (Annual)26.01x
Revenue / Share (TTM)$26.36
ROE (TTM)0.17%
52-Week Low$22.66

Analyst Recommendations

Jan 2026
Feb 2026
Mar 2026
Apr 2026
3.86
3.93
4.07
4.07

Industry Peers — Electronic Computers(6)

SymbolP/S Ratio (TTM)Revenue Growth TTM (YoY)Gross Margin (TTM)Forward P/EPrice
OMCLOmnicell Inc
1.47x6.53%42.49%21.86x$38.28
AAPLApple Inc.
9.11x10.07%47.33%31.85x$270.23
DELLDell Technologies Inc.
1.12x18.80%20.00%15.44x$196.55
SMCISuper Micro Computer, Inc. Common Stock
0.61x34.76%8.02%12.86x$28.56
OSSOne Stop Systems, Inc. Common Stock
4.07x14.33%29.01%$9.92
ZEPPZepp Health Corporation American depositary shares, each representing sixteen Class A ordinary shares
1.73x-34.33%37.58%$16.33
SCKTSocket Mobile, Inc. New
0.48x-13.00%49.93%$0.93

About

Omnicell Inc develops automation and analytics software that streamlines medication management for healthcare providers. The company's solutions enable pharmacists and nurses to reduce administrative work while improving patient care and driving better clinical, operational, and financial outcomes. Revenue is primarily generated from the United States market.